Paying users zone. Data is covered by .
Get to Bristol-Myers Squibb Co. for $17.99, or
get to entire website for at least 3 months from $49.99.
Enterprise Value to FCFF (EV/FCFF)
Free Cash Flow to The Firm (FCFF)
Bristol-Myers Squibb Co., FCFF calculation
USD $ in millions
|FCFF||Free cash flow to the firm is the cash flow available to the Bristol-Myers Squibb Co.’s suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.||Bristol-Myers Squibb Co.’s FCFF increased from 2015 to 2016 and from 2016 to 2017.|
Interest Paid, Net of Tax
Bristol-Myers Squibb Co., interest paid, net of tax calculation
USD $ in millions
|12 months ended||Dec 31, 2017||Dec 31, 2016||Dec 31, 2015||Dec 31, 2014||Dec 31, 2013|
|Effective Income Tax Rate (EITR)|
|Interest Paid, Net of Tax|
|Interest payments, before tax|
|Less: Interest payments, tax2|
|Interest payments, net of tax|
2 Interest payments, tax = Interest payments × EITR
= × =
Enterprise Value to FCFF Ratio, Current
Bristol-Myers Squibb Co., current EV/FCFF calculation, comparison to benchmarks
|Selected Financial Data (USD $ in millions)|
|Enterprise value (EV)|
|Free cash flow to the firm (FCFF)|
|Eli Lilly & Co.|
|Gilead Sciences Inc.|
|Johnson & Johnson|
|Merck & Co. Inc.|
|Regeneron Pharmaceuticals Inc.|
|Pharmaceuticals & Biotechnology|
Based on: 10-K (filing date: 2018-02-13).
If company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.
Enterprise Value to FCFF Ratio, Historical
Bristol-Myers Squibb Co., historical EV/FCFF calculation, comparison to benchmarks
3 EV/FCFF = EV ÷ FCFF
= ÷ =
|EV/FCFF||Enterprise value to free cash flow to the firm is whole company valuation indicator.||Bristol-Myers Squibb Co.’s EV/FCFF ratio declined from 2015 to 2016 and from 2016 to 2017.|